Gelfand Lab
The Gelfand Clinical Research Lab designs and conducts clinic-based and population-based observational studies and interventional and translational clinical trials in common and rare skin diseases. Dr. Gelfand and his team focus on pharmacoepidemiology, patient-centered outcomes and effectiveness research, psychometrics and instrument/diagnostic test development, and human translational studies aimed at the development of novel treatment approaches and further understanding of disease pathogenesis. A major goal of the Gelfand Clinical Research Program is to improve psoriasis patient outcomes in the skin and joints, while lowering the risk of diabetes, cardiovascular disease and mortality. A full list of our current research projects can be found in the Research tab.
Announcements
Welcome to our newest member of the team!
Read more about him on our Team page.
Most recent publications:
Risk of Inflammatory Bowel Disease in Patients with Atopic Dermatitis
Incidence of Cardiovascular Disease and Venous Thromboembolism in Patients with Atopic Dermatitis
Cardiovascular Health in People with Psoriasis: A Population-Based Study in the United States
Autoimmune Diseases and Cardiovascular Risk
Opportunities in the Gelfand Lab:
Fellowship Opportunities
Job Opportunities:
-
Clinical Research Coordinator A (Marketing and Recruitment)(Department of Dermatology)
-
Clinical Research Coordinator B (Regulatory Coordinator)(Department of Dermatology)
-
Clinical Research Coordinator B (Fiscal)(Department of Dermatology)
Join Us on the Research Bus to Success!
